Search alternatives:
significant predictor » significant predictors (Expand Search), significant reduction (Expand Search), significant factor (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant predictor » significant predictors (Expand Search), significant reduction (Expand Search), significant factor (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
-
1981
-
1982
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
1983
-
1984
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
1985
-
1986
-
1987
-
1988
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
1989
-
1990
-
1991
-
1992
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
1993
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
1994
-
1995
-
1996
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
1997
-
1998
-
1999
-
2000